Vyoshadi Varlepa and Dhatrikhadirkwath Treatment in vitiligo

Comparative study of efficacy of vyoshadi varlepa and dhatrikhadira kwatha on shvitra - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070687

Enrollment

Registered

2024-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects of either sex will be taken. Subjects having age between 25 to 50 years will be selected with chronicity of less than 10 years Subjects having classical sign and symptoms of Shvitra Arunata, Mandala, Rukshata, Paridhvanshi for Vatik Shvitra. Padampatra Pratikasham, Sadaha, Romavidhvanshi, Tamra for Paitika Shvitra. Kandu, Shveta, Bahala, Snigdha for Shleshmika Shvitra.

Exclusion criteria

Exclusion criteria: Subjects having any systemic illness. Subjects not willing to participate in the study. Subjects having chronicity more than 10 years. Subjects having serious cardiac, renal, hepatic diseases, other condition like insulin dependent diabetes mellitus (IDDM) & non IDDM. Gravid and lactating women were also excluded. Subjects having patches due to burning or chemical explosion. Subjects having lesions at Guhyanga (genital organ), Panipadatala (Sole of palm and foot), Oshtha (Lips), Aekanga (generalized lesion), Sarvanga (generalized lesion) and patches with Raktaroma (reddish hair) and Samsakta (coalescent).

Design outcomes

Primary

Measure	Time frame
The primary outcome of this study was to evaluate and compare the efficacy of Vyoshadi Varlepa and Dhatrikhadira Kwatha in the treatment of Shvitra. The effectiveness of these treatments will be assessed based on the degree of repigmentation observed in depigmented patches, the reduction in the size of these patches, and overall improvement in skin health.Timepoint: 90 days	—

Secondary

Measure	Time frame
The secondary outcomes of this study to evaluate additional aspects of the treatments effectiveness & their impact on the quality of life for patients with Shvitra (vitiligo). These included: Patient Quality of Life Patient Satisfaction Adverse Effects Pigmentation Stability Inflammation & Itching Timepoint: After complition of study every 15 days	—

Countries

India

Contacts

Public ContactProf Dr Rajesh Kumar Sharma

Post Graduate Institute of Ayurved DSRRAU Jodhpur

pareekpooja911@gmail.com7737219364

Outcome results